Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1338-1344
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1338
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1338
Table 3 TGR5 expression in different clinical stages of esophageal adenocarcinoma n (%)
| Clinical stage | Negative | Weak | Moderate | Strong | |
| I and II, n = 9 | 0 | 0 | 4 (44.4) | 5 (55.6) | |
| III and IV, n = 7 | 0 | 0 | 3 (42.9) | 4 (57.1) | P > 0.05 |
- Citation: Marketkar S, Li D, Yang D, Cao W. TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett’s esophagus: Case series and findings. World J Gastroenterol 2017; 23(8): 1338-1344
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1338.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1338